Skip to main content
. Author manuscript; available in PMC: 2022 Jun 23.
Published in final edited form as: Psychooncology. 2021 Sep 4;31(2):306–315. doi: 10.1002/pon.5811

Table 3:

Association between albumin and depression or anxiety in patients with metastatic cancers (n=50) using all available laboratory values (Model 1) and those drawn within 1 week of visit in CL clinic (Model 2) (n=27).

Depression Confidence Interval
Model 1 (any available lab value) Regression Coefficient β P Lower Upper
Age −.03 (.07) −.06 .65 −.166 .105
Sex −1.21 (1.89) −.09 .53 −5.001 2.587
Albumin −4.30 (2.06) −.29 .04* −8.450 −.158
adjusted R2 .05; F=1.841, p=.15
Anxiety Confidence Interval
Model 1 (any available lab value) Regression Coefficient β P Lower Upper
Age −.09 (.07) −.18 .21 −.225 .050
Sex −.25 (1.91) −.02 .90 −4.094 3.589
Albumin −4.46 (2.09) −.30 .04* −8.660 −.264
adjusted R2 .069 F=2.210, p=.10
Depression Confidence Interval
Model 2: (lab within a week) Regression Coefficient β P Lower Upper
Age −.13 (.10) −.22 .20 −.331 .073
Sex 1.60 (2.17) .13 .47 −2.892 6.094
Albumin −9.56 (2.69) −.63 .002** −15.141 −3.975
adjusted R2 .32, F=4.927, p=.009**
Anxiety Confidence Interval
Model 2: (lab within a week) Regression Coefficient β P Lower Upper
Age −.22 (.12) −.36 .08 −.467 .024
Sex −.42 (2.64) −.03 .87 −5.890 5.044
Albumin −6.03 (3.28) −.36 .08 −12.818 .769
adjusted R2 .16, F=2.527, p=.08

Note:

*

p<.05

**

p<.01.